Riedel's Thyroiditis: What to Do When Tamoxifen Has Not Worked

Riedel's thyroiditis is a rare fibrosing inflammatory disorder of the thyroid. When an initial treatment line does not produce sufficient reduction of thyroid mass or adequate symptom control, a structured next-step protocol is indicated.

Previous Treatment — Failure Condition Tamoxifen — given either alongside continued corticosteroid therapy or as monotherapy — did not achieve the required goals: significant reduction of thyroid mass size and control of clinical symptoms. This protocol addresses that escalation point.
Next-Step Approach (partial overview) The protocol for this situation involves a combination immunosuppressive regimen. The specific agents, sequence, and complete management details are contained in the full structured protocol — access it below.
Clinical Goals Significant reduction of goiter size and symptomatic relief.

References

DOI: 10.1210/jc.2011-0617

A recent report demonstrates significant reduction of goiter size using a combination of mycophenolate mofetil (1 g twice daily) and 100 mg prednisone daily.

The addition of mycophenolate mofetil resulted in symptomatic relief and successful subtotal thyroidectomy after 90 d of treatment.

View source ↗